Ignite Creation Date:
2024-05-06 @ 4:03 PM
Last Modification Date:
2024-10-26 @ 2:02 PM
Study NCT ID:
NCT04857307
Status:
COMPLETED
Last Update Posted:
2022-06-30
First Post:
2021-04-22
Brief Title:
A Study to Assess the Pharmacokinetics PK and Safety of Staccato Alprazolam in Adolescent Study Participants With Epilepsy
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Study Overview
Official Title:
A Multicenter Open-Label Study to Evaluate the Pharmacokinetics Tolerability and Safety of a Single Dose of Staccato Alprazolam in Adolescent Study Participants With Epilepsy
Status:
COMPLETED
Status Verified Date:
2022-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to assess the pharmacokinetics PK tolerability and safety of Staccato alprazolam in adolescent study participants with epilepsy following single-dose administration
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None